Speech Pathology Telepractice Beneficial in Head, Neck Cancer

This article originally appeared here.
Share this content:
Speech Pathology Telepractice Beneficial in Head, Neck Cancer
Speech Pathology Telepractice Beneficial in Head, Neck Cancer

FRIDAY, March 3, 2017 (HealthDay News) -- For patients with head and neck cancer, a multisite speech pathology telepractice service is associated with higher service efficiency and treatment satisfaction compared with standard care, according to a study published online Feb. 22 in Head & Neck.

Clare L. Burns, Ph.D., from Royal Brisbane and Women's Hospital in Australia, and colleagues conducted a multicenter controlled trial within a large public cancer service. Referrals from speech pathologists at three regional sites were managed by a specialist clinician from a cancer center via standard care, which comprised phone, e-mail support, and appointments at the cancer center, or via a newly established telepractice service, which included online consultation between the cancer center and the regional sites. Data were included for 82 referrals that were managed: 39 for standard care and 43 for telepractice care.

The researchers found that service efficiency favored the telepractice model, with a significant decrease in the number and duration of contact events needed for referral management (P = 0.004 and P = 0.024, respectively). The telepractice service also had higher consumer and clinician satisfaction.

"A speech pathology telepractice service benefits both the patient and health provider through higher service efficiency and treatment satisfaction," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »